Home
About
Overview
Sharing Data
ORCID
Help
History (11)
The expanding use of third-generation aromatase inhibitors: what the general internist needs to know.
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
The effects of brain death and ischemia on tolerance induction are organ-specific.
A response to "Personalised medicine and population health: breast and ovarian cancer".
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A response to "Personalised medicine and population health: breast and ovarian cancer".
A response to "Personalised medicine and population health: breast and ovarian cancer". Hum Genet. 2019 Mar; 138(3):287-289.
View in:
PubMed
subject areas
Breast Neoplasms
Early Detection of Cancer
Female
Health Care Costs
Humans
Ovarian Neoplasms
Population Health
Precision Medicine
authors with profiles
Olufunmilayo Olopade